Lorraine S. Evangelista is a Professor and Associate Dean for Research and Scholarship and the Lena Finke Distinguished Chair for Nursing Arts at the University of Texas Medical Branch in Galveston, Texas. She completed her baccalaureate training at the University of the Philippines College of Nursing (cum laude) in 1985. She received her master’s and doctoral degree from the UCLA School of Nursing in 1993 and 2000, respectively. She is recognized internationally for her investigation into the care of patients with heart disease and the effects of this disease on the patients and family members. She has over 120 publications on adherence, self-care, quality of life, and health literacy. In 2017, she completed a U.S. Fulbright scholarship to study the lifestyle behaviors and risk factors of Filipinos in underserved communities.
Pei-Yong Shi, PhD, is I.H. Kempner Professor of Human Genetics, University of Texas Medical Branch, Galveston Texas. He is an elected Fellow of American Academy of Microbiology, adjunct Professor of Emerging Infectious Diseases at the Duke-NUS Graduate Medical School in Singapore, and Honorary Professor at the Wuhan Institute of Virology, Chinese Academy of Sciences. He received his Ph.D. in virology in 1996 from Georgia State University. After postdoctoral training at Yale University, he joined Bristol-Myers Squibb as a Principal Scientist to develop HIV and HCV therapeutics from 1998 to 2000. He then moved to the Wadsworth Center, New York State Department of Health, to study West Nile virus. From 2008 to 2015, he served as Dengue Unit Head and Executive Director to lead drug discovery at Novartis Institute for Tropical Diseases. His group developed the first infectious clones of the epidemic strain of West Nile virus and Zika virus, discovered two RNA cap methylation activities of flavivirus NS5 protein, identified essential RNA elements for flavivirus replication, established various platforms for flavivirus vaccine and drug discovery, and pioneered therapeutics development for dengue virus. He has published over 260 peer-reviewed articles and served as Editor (ACS Infectious Diseases, Nature Vaccine) and Editorial Board member (Journal of Virology, Virology, and Antiviral Research). He is internationally recognized for his scholar and administrative accomplishments at leading research institution, public health sector, and pharmaceutical industry.
Dr. Modave is the Director of the Center for Health Outcomes and Informatics Research, chair of the Department of Health Informatics and Data Science, and Associate Provost in the Health Sciences Division at Loyola University Chicago.
He has an extensive background in informatics and health outcomes—his most recent role was Associate Professor and Director of the University of Florida’s Health Cancer Center eHealth Core within the Department of Health Outcomes and Biomedical Informatics.
He is currently the Loyola site-PI for the Institute for Translational Medicine, the Chicago-area Clinical and Translational Science Award, led by University of Chicago and Rush University.
He grew up in Paris, France where he received a BS in Mathematics and Computer Science, and a MS in Mathematics Applied to Engineering. Dr. Modave completed a PhD in Computer Science in Toulouse, France with a focus on data science.
His research is focused on biomedical informatics and machine learning, using it to create interventions for obesity, weight management, and cancer control. Dr. Modave is also focused on developing software to improve decision making in cancer screening and other public health issues. His research has been funded by the National Institutes of Health (NCI, NCATS), the National Science Foundation, as well as IBM and NASA/Boeing.
Katrina Lambrecht, JD, MBA, serves as Vice President, Health System Operations & Regional Hospitals at the University of Texas Medical Branch (UTMB).
In this role, Ms. Lambrecht provides strategic and operational leadership for the hospitals in UTMB’s regional markets. This includes the Angleton Danbury Campus, League City Campus, and the Clear Lake Campus. She oversees UTMB's collaborative partnership with the University of Texas MD Anderson Cancer Center, who has an outpatient facility on UTMB's League City Campus and provides outpatient services through the partnership on the Galveston Campus.
Ms. Lambrecht is also responsible for implementation of population health strategies and models for payment reform, facilitating a governance structure to achieve value-based reimbursement metrics under the various alternative payment model arrangements including individual payer accountable care contracts and the Delivery System Reform Incentive Program under the Medicaid 1115 Waiver program. Under the Medicaid 1115 Waiver, UTMB also serves as the anchor for a 16-county region in southeast Texas. As the anchor, UTMB serves a convener role for providers, provides technical assistance to regional providers, communicates with Health and Human Services Commission (HHSC) of Texas on behalf of the region, and handles semi-annual reporting for providers.
Ms. Lambrecht leads Access Operations & Services and Care Transitions across the health system. This includes access services, patient placement center, care management and social work across the care continuum, utilization management, and the health maintenance team. She also has oversight of the UTMB Multi-share program, a health benefits program for small businesses with less than 50 employees in Galveston County.
Katrina earned both her JD and her MBA from the University of Wisconsin in Madison, Wisconsin.